z-logo
Premium
Germ cell neoplasia in situ ( GCNIS ): evolution of the current nomenclature for testicular pre‐invasive germ cell malignancy
Author(s) -
Berney Daniel M,
Looijenga Leendert H J,
Idrees Muhammad,
Oosterhuis J Wolter,
RajpertDe Meyts Ewa,
Ulbright Thomas M,
Skakkebaek Niels E
Publication year - 2016
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/his.12958
Subject(s) - germ cell , malignancy , carcinoma in situ , germ , germ cell tumors , biology , in situ , cell , pathology , medicine , microbiology and biotechnology , chemistry , carcinoma , genetics , chemotherapy , gene , organic chemistry
The pre‐invasive lesion associated with post‐pubertal malignant germ cell tumours of the testis was first recognized in the early 1970s and confirmed by a number of observational and follow‐up studies. Until this year, this scientific story has been confused by resistance to the entity and disagreement on its name. Initially termed ‘carcinoma in situ ’ ( CIS ), it has also been known as ‘intratubular germ cell neoplasia, unclassified’ ( IGCNU ) and ‘testicular intraepithelial neoplasia’ ( TIN ). In this paper, we review the history of discovery and controversy concerning these names and introduce the reasoning for uniting behind a new name, endorsed unanimously at the World Health Organization ( WHO ) consensus classification 2016: germ cell neoplasia in situ ( GCNIS ).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom